STOCK TITAN

Constellium SE Form 4 Filings

CSTM NYSE

Every Form 4 that Constellium SE (CSTM) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CSTM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CSTM filings page.

Rhea-AI Summary

Constellium SE director Jean-Christophe Deslarzes purchased 1,490 ordinary shares on 2026-08-03 at $27.24 per share in a non-derivative transaction. Following this purchase, he directly holds 43,515 shares of Constellium SE. The Rule 10b5-1 trading-plan checkbox is unchecked.

Rhea-AI Summary

Constellium SE CEO Ingrid Joerg reported a tax-withholding disposition of 2,984 ordinary shares on July 10, 2026. The shares were withheld by the issuer to satisfy tax withholding obligations and are described as not a discretionary transaction by the reporting person. After this event, Joerg directly holds 406,464 ordinary shares.

Rhea-AI Summary

CONSTELLIUM SE director John Ormerod sold 8,000 ordinary shares in an open-market transaction at an average price of $35.01 per share. After this sale, he directly holds 24,873 ordinary shares, indicating he retains a meaningful equity position in the company.

Rhea-AI Summary

Constellium SE senior vice president and chief procurement officer Marcus Becker sold ordinary shares in an open-market transaction. On this date, he sold 10,391 ordinary shares at a weighted average price of $34.93 per share, in multiple trades between $34.87 and $35.03. After the sale, he directly owned 16,784 ordinary shares of Constellium SE.

Rhea-AI Summary

Constellium SE director Bradley Lee Soultz reported an open-market purchase of 2,500 ordinary shares at a weighted average price of $33.84 per share through the Bradley L. Soultz Irrevocable Trust. After this transaction, he holds 12,500 ordinary shares directly and 2,500 shares indirectly via the trust.

Rhea-AI Summary

Constellium SE senior vice president and Chief Innovation Officer Jarrett Martin sold 4,716 ordinary shares in an open-market transaction. The shares were sold on May 14, 2026 at a weighted average price of $33.46, with individual trade prices ranging from $33.41 to $33.55. After the sale, Martin directly holds 15,375 ordinary shares of Constellium SE.

Rhea-AI Summary

Constellium SE senior vice president Ludovic Piquier sold 1,000 ordinary shares in an open-market transaction. The sale took place on May 12, 2026 at a weighted average price of $33.57 per share, with individual trade prices ranging from $33.41 to $33.70.

After this sale, Piquier directly owns 241,713 ordinary shares of Constellium SE. The filing notes that detailed trade-by-trade pricing within the stated range is available upon request.

Rhea-AI Summary

Constellium SE senior vice president Nicolas Brun reported an open-market sale of ordinary shares. On May 11, 2026, he sold 26,661 ordinary shares of Constellium at a weighted average price of $33.85 per share across multiple trades between $33.79 and $34.04. After this transaction, Brun directly holds 104,891 ordinary shares of Constellium.

Rhea-AI Summary

Constellium SE executive Stephane Corre, President of Automotive Structures & Industry, sold 5,000 ordinary shares in an open-market transaction at a weighted average price of $33.52 per share on May 8, 2026. After this sale, he directly holds 62,313 ordinary shares.

Rhea-AI Summary

Constellium SE director Michiel Brandjes sold ordinary shares in an open-market transaction. On the reported date, he sold 10,400 ordinary shares at a weighted-average price of $31.25 per share, with individual trade prices ranging from $31.00 to $33.00. Following this sale, he directly holds 41,600 ordinary shares.

Rhea-AI Summary

Constellium SE’s EVP & CFO, Jack Q. Guo, completed an open-market sale of 25,201 ordinary shares of the company on May 5, 2026. The weighted average sale price was $32.62 per share, with individual trades executed between $32.62 and $32.68. After this transaction, he continues to directly hold 185,368 ordinary shares of Constellium, indicating he retained a substantial equity stake following the sale.

Rhea-AI Summary

CONSTELLIUM SE executive Philippe Hoffmann, President, A&T, sold 50,000 ordinary shares in an open-market transaction. The weighted average sale price was $31.92 per share, with individual trades ranging from $31.77 to $32.16. After this sale, Hoffmann directly holds 144,153 ordinary shares of Constellium.

Rhea-AI Summary

Constellium SE senior executive Philip Ryan Jurkovic reported an open-market sale of company stock. As SVP & CHRO, he sold 48,784 ordinary shares of Constellium SE on May 1, 2026 at a weighted average price of $32.01 per share in multiple transactions.

After these sales, Jurkovic directly holds 172,149 ordinary shares of Constellium SE. According to the filing, the trades were executed within a price range of $32.00 to $32.10, and detailed breakdowns by individual trade price are available upon request from the company or the SEC staff.

Rhea-AI Summary

CONSTELLIUM SE executive Stephane Corre, President of AS&I, sold 5,000 ordinary shares in an open-market transaction at a weighted average price of $32.04 per share. After this sale, he directly holds 67,313 ordinary shares.

Rhea-AI Summary

Constellium SE director Jean-Christophe Deslarzes purchased additional shares of the company. He made an open-market purchase of 1,325 ordinary shares of CSTM at a price of $31.13 per share. Following this transaction, he directly owns 42,025 ordinary shares of Constellium SE.

Rhea-AI Summary

Constellium SE senior vice president and chief procurement officer Marcus Becker sold 10,000 ordinary shares in an open-market transaction. The shares were sold at a weighted average price of $25.09 per share, with individual trade prices ranging from $25.08 to $25.11. Following this sale, he continues to directly own 27,175 ordinary shares of Constellium SE.

Rhea-AI Summary

CONSTELLIUM SE director Jean-Christophe Deslarzes bought 1,665 ordinary shares in the open market. The purchase took place on March 2, 2026 at a price of $24.77 per share. After this transaction, he directly owns 40,700 ordinary shares of Constelium.

Rhea-AI Summary

CONSTELLIUM SE reported that SVP GC & Secretary Stephen Charles Walters received a grant or award of 5,834 ordinary shares on 2026-03-12. Following this acquisition, he directly owns a total of 25,068 ordinary shares.

Rhea-AI Summary

Weiler Wiebke reported acquisition or exercise transactions in this Form 4 filing.

CONSTELLIUM SE director Wiebke Weiler received an equity grant tied to future service. The filing reports an award of 625 ordinary-share-based restricted stock units, which vest in full on March 12, 2029, subject to the director’s continued employment. Following this grant, Weiler’s reported direct holdings total 625 shares.

Rhea-AI Summary

Brun Nicolas reported acquisition or exercise transactions in this Form 4 filing.

CONSTELLIUM SE senior vice president Nicolas Brun reported an equity compensation award rather than a market purchase. He received 4,376 ordinary shares in the form of restricted stock units that were granted at no cash cost. These units vest in full on March 12, 2029, subject to his continued employment. Following this award, he is shown as holding 131,552 ordinary shares directly.

Rhea-AI Summary

Jurkovic Philip Ryan reported acquisition or exercise transactions in this Form 4 filing.

Constellium SE senior vice president and CHRO Philip Ryan Jurkovic received a grant of 10,210 restricted stock units representing ordinary shares as executive compensation. The award was reported at a price of zero per share and increases his direct holdings to 220,933 ordinary shares.

The restricted stock units vest in full on March 12, 2029, subject to his continued employment, meaning he must remain with the company until that date to receive the underlying shares.

Rhea-AI Summary

CONSTELLIUM SE senior vice president Ludovic Piquier reported an acquisition of 5,469 ordinary shares through a grant of restricted stock units. The units were granted at no cash cost and will vest in full on March 12, 2029, conditioned on his continued employment.

Following this equity award, Piquier directly holds 242,713 ordinary shares. This filing reflects a compensation-related stock grant rather than an open-market purchase or sale, increasing his long-term ownership stake in the company.

Rhea-AI Summary

Becker Marcus reported acquisition or exercise transactions in this Form 4 filing.

Constellium SE reported that senior vice president and chief procurement officer Marcus Becker received a grant of 3,938 restricted stock units representing ordinary shares. These units were awarded at no cash cost and vest in full on March 12, 2029, subject to his continued employment. Following this compensation-related award, Becker directly owns 37,175 ordinary shares.

Rhea-AI Summary

Joerg Ingrid reported acquisition or exercise transactions in this Form 4 filing.

CONSTELLIUM SE CEO Ingrid Joerg received a compensation-related equity grant. On March 12, 2026, she was awarded 31,358 ordinary shares in the form of restricted stock units, which vest in full on March 12, 2029, subject to continued employment. After this grant, she directly holds 409,448 shares.

Rhea-AI Summary

Perkins Matthew B. reported acquisition or exercise transactions in this Form 4 filing.

CONSTELLIUM SE reported that executive Matthew B. Perkins, President, P&ARP, received an equity award in the form of 10,210 ordinary shares on March 12, 2026. The award was recorded at a price of $0.00 per share, indicating it is a compensation grant rather than an open-market purchase.

According to the footnote, this represents a grant of restricted stock units that vest in full on March 12, 2029, provided he remains employed through that date. Following this grant, Perkins directly holds 33,212 ordinary shares, reflecting his ongoing equity-based alignment with the company.

Rhea-AI Summary

Schild Niklaus reported acquisition or exercise transactions in this Form 4 filing.

Constellium SE senior vice president and chief information and digital officer Niklaus Schild reported an equity compensation award. He received 3,355 restricted stock units tied to Constellium ordinary shares, granted at no purchase price. These units vest in full on March 12, 2029, subject to his continued employment.

Following this grant, Schild directly holds 38,703 ordinary shares of Constellium. The transaction reflects routine stock-based compensation rather than an open-market share purchase or sale.

Rhea-AI Summary

Hoffmann Philippe reported acquisition or exercise transactions in this Form 4 filing.

CONSTELLIUM SE reported that President, A&T Philippe Hoffmann received an equity award in the form of restricted stock units. On March 12, 2026, he was granted 12,033 ordinary shares at a price of $0.00 per share as compensation. Following this grant, his direct holdings increased to 194,153 ordinary shares. According to the disclosure, these restricted stock units vest in full on March 12, 2029, provided he remains employed with the company through that date.

Rhea-AI Summary

Corre Stephane reported acquisition or exercise transactions in this Form 4 filing.

Constellium SE reported that executive Stephane Corre, President of Automotive Structures & Industry, received a grant of 7,293 ordinary shares in the form of restricted stock units at no cash cost. These units vest in full on March 12, 2029, contingent on his continued employment. Following this equity award, Corre directly holds 72,313 ordinary shares of Constellium, aligning a portion of his compensation with the company’s long-term share performance.

Rhea-AI Summary

Guo Jack Q. reported acquisition or exercise transactions in this Form 4 filing.

Constellium SE EVP & CFO Jack Q. Guo received a grant of 19,690 ordinary shares in the form of restricted stock units, with no purchase price.

Following this award, he directly holds 210,569 ordinary shares. The RSUs vest in full on March 12, 2029, subject to continued employment.

Rhea-AI Summary

Constellium SE executive Stephane Corre, President of the Automotive Structures & Industry segment, sold 1,500 ordinary shares in an open-market transaction at a weighted average price of $25.89 per share on March 10, 2026. After this sale, he directly holds 65,020 ordinary shares. The transaction was executed through multiple trades within a narrow price range of $25.88 to $25.89 per share, indicating a relatively small, routine disposition compared with his remaining stake.

Rhea-AI Summary

Corre Stephane reported open-market purchase transactions in this Form 4 filing.

Constellium SE President, AS&I Stephane Corre acquired 8,026 ordinary shares of the company. These shares represent earned non-derivative performance stock units that were granted on March 9, 2023 and vested on March 9, 2026. Following this award vesting, Corre directly holds 66,520 ordinary shares.

Rhea-AI Summary

CONSTELLIUM SE President, A&T Philippe Hoffmann reported compensation-related share movements. On March 9, 2026, 71,132 ordinary shares were delivered upon vesting of performance-based stock unit awards granted on March 9, 2023. On March 10, 2026, he sold 4,728 ordinary shares solely to cover tax withholding obligations from those vestings, and held 182,120 shares afterward.

Rhea-AI Summary

Constellium SE senior vice president and chief procurement officer Marcus Becker reported the vesting of performance-based stock awards and a small related share sale. On March 9, 2026, previously granted performance stock units vested, delivering 14,592 ordinary shares at no cash purchase price.

On March 10, 2026, Becker disposed of 1,113 ordinary shares solely to satisfy tax withholding obligations triggered by the vesting of restricted stock unit and performance stock unit awards. After these transactions, he directly held 33,237 ordinary shares, reflecting a net increase in his equity position.

Rhea-AI Summary

Constellium SE CEO Ingrid Joerg reported a mix of equity compensation and a small tax-related sale. On March 9, 2026, she acquired 71,132 ordinary shares at no cost from performance stock units granted on March 9, 2023 that vested after meeting performance conditions. On March 10, 2026, she sold 4,614 ordinary shares at $25.87 per share solely to cover tax withholding obligations from the vesting of restricted and performance stock unit awards. After these transactions, she directly held 378,090 ordinary shares.

Rhea-AI Summary

CONSTELLIUM SE EVP & CFO Jack Q. Guo reported a mix of stock award vesting and related share sales. On March 9, 2026, he acquired 75,874 ordinary shares through vested stock awards at $0.00 per share. On March 10, 2026, he sold 41,717 ordinary shares at $25.87 per share, and a footnote explains this sale was made solely to satisfy tax withholding obligations upon vesting of prior restricted and performance stock unit awards. After these transactions, he directly owns 190,879 ordinary shares of Constellium.

Rhea-AI Summary

Constellium SE senior executive Philip Ryan Jurkovic reported compensation-related share activity. On March 9, 2026, he acquired 59,276 ordinary shares of Constellium through earned performance stock units granted on March 9, 2023 that vested on that date.

On March 10, 2026, he sold 29,900 ordinary shares at $25.87 per share solely to satisfy tax withholding obligations triggered by the vesting of restricted stock unit and performance stock unit awards. After these transactions, he directly owned 210,723 ordinary shares, indicating a largely retained equity position.

Rhea-AI Summary

CONSTELLIUM SE reported that senior vice president for Manufacturing Excellence and CTO Ludovic Piquier acquired 30,350 ordinary shares on March 9, 2026 through an equity award. These shares reflect earned performance stock units granted on March 9, 2023 that vested based on performance conditions. Following this grant, Piquier directly owns 237,244 ordinary shares, highlighting ongoing equity-based compensation rather than an open-market purchase.

Rhea-AI Summary

Schild Niklaus reported acquisition or exercise transactions in this Form 4 filing.

Constellium SE senior vice president and CIO/CDO Niklaus Schild reported receiving 5,106 ordinary shares as a grant or award. These shares reflect earned performance stock units that were originally granted on March 9, 2023 and vested on March 9, 2026. After this award, Schild directly holds 35,348 ordinary shares, highlighting a routine, compensation-related increase in his equity stake.

Rhea-AI Summary

Constellium SE senior vice president Nicolas Brun reported two transactions in the company’s ordinary shares. On March 9, 2026, he completed an open-market sale of 17,701 shares at a weighted-average price of $24.67 per share, with individual trades ranging from $24.63 to $24.72. The same day, he acquired 23,710 shares at no cost, representing earned performance stock units originally granted on March 9, 2023 that vested on March 9, 2026. Following these transactions, Brun directly holds 127,176 ordinary shares of Constellium SE.

Rhea-AI Summary

Constellium SE executive Philippe Hoffmann, President A&T, reported selling a total of 80,000 ordinary shares in two open-market transactions on March 4, 2026. One sale covered 50,000 shares at a weighted average price of $26.03, and another covered 30,000 shares at a weighted average price of $27.14. After these sales, he directly owned 55,425 ordinary shares.

Rhea-AI Summary

Constellium SE executive Stephane Corre, President of AS&I, reported an open-market sale of 3,000 ordinary shares on February 27, 2026 at a weighted average price of $24.69 per share, executed in multiple trades between $24.67 and $24.72. After these transactions, Corre directly owns 44,444 ordinary shares.

Rhea-AI Summary

Constellium SE director Isabelle Boccon-Gibod reported an open-market sale of 10,000 ordinary shares. The sale took place on February 26, 2026 at a weighted average price of $25.77 per share, executed through multiple transactions at that price. After this sale, she directly owns 23,000 ordinary shares of Constellium SE.

Rhea-AI Summary

CONSTELLIUM SE executive Stephane Corre sold 3,200 ordinary shares in an open-market transaction. The shares were sold on February 25, 2026 at a weighted average price of $25.7068 per share, leaving him with 47,444 ordinary shares held directly after the sale.

Rhea-AI Summary

Constellium SE senior vice president and chief production officer Marcus Becker reported an open-market sale of company stock. On February 20, 2026, he sold 15,570 ordinary shares of Constellium SE at a weighted average price of $25.5793 per share, in transactions described as occurring within that same price level. After this sale, his directly held ordinary shares reported in this filing were reduced to zero.

Rhea-AI Summary

Constellium SE senior vice president, general counsel and secretary Stephen Charles Walters reported an open-market sale of 1,500 ordinary shares on February 23, 2026. The shares were sold at a weighted average price of $25.39 per share, and his directly held stake is now reported as 0 shares.